Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
11%
upside
3 price targets
|
0
%
|
|
|
|
11%
upside
11 price targets
|
0
%
|
|
|
|
11%
upside
5 price targets
|
0
%
|
|
|
279
Tandem Diabetes Care
TNDM
$1.5B
|
10%
upside
7 price targets
|
0
%
|
|
|
10%
upside
3 price targets
|
0
%
|
|
|
|
9%
upside
5 price targets
|
0
%
|
|
|
|
9%
upside
6 price targets
|
0
%
|
|
|
|
9%
upside
4 price targets
|
0
%
|
|
|
|
9%
upside
3 price targets
|
0
%
|
|
|
|
9%
upside
3 price targets
|
0
%
|
|
|
286
Crescent Capital BDC
CCAP
$551M
|
9%
upside
3 price targets
|
0
%
|
|
|
9%
upside
4 price targets
|
0
%
|
|
|
|
8%
upside
3 price targets
|
0
%
|
|
|
|
8%
upside
5 price targets
|
0
%
|
|
|
|
8%
upside
4 price targets
|
0
%
|
|
|
|
8%
upside
5 price targets
|
0
%
|
|
|
|
8%
upside
3 price targets
|
0
%
|
|
|
|
7%
upside
5 price targets
|
0
%
|
|
|
|
7%
upside
4 price targets
|
0
%
|
|
|
|
7%
upside
6 price targets
|
0
%
|
|
|
|
6%
upside
3 price targets
|
0
%
|
|
|
|
6%
upside
6 price targets
|
0
%
|
|
|
|
6%
upside
4 price targets
|
0
%
|
|
|
|
6%
upside
3 price targets
|
0
%
|
|
|
|
6%
upside
3 price targets
|
0
%
|
|